Karyopharm Therapeutics Inc. Annual Interest Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Karyopharm Therapeutics Inc. quarterly/annual Interest Expense history and growth rate from 2014 to 2023.
  • Karyopharm Therapeutics Inc. Interest Expense for the quarter ending June 30, 2024 was $8.95M, a 54.7% increase year-over-year.
  • Karyopharm Therapeutics Inc. Interest Expense for the twelve months ending June 30, 2024 was $27.1M, a 15.2% increase year-over-year.
  • Karyopharm Therapeutics Inc. annual Interest Expense for 2023 was $23.8M, a 4.69% decline from 2022.
  • Karyopharm Therapeutics Inc. annual Interest Expense for 2022 was $25M, a 4.03% decline from 2021.
  • Karyopharm Therapeutics Inc. annual Interest Expense for 2021 was $26M, a 4.03% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $23.8M -$1.17M -4.69% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $25M -$1.05M -4.03% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $26M -$1.09M -4.03% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $27.1M +$11.5M +73.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 $15.6M +$13.2M +528% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $2.49M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2014 $1K* Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.